FDA Warning on Transmucosal Buprenorphine Issued

The U.S. Food and Drug Administration (FDA) has released a warning on the use of transmucosal buprenorphine, a drug prescribed to treat opioid use disorder and pain. They warn that it may cause dental problems.

Read more.